Filing Details
- Accession Number:
- 0000914062-14-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-02 17:31:28
- Reporting Period:
- 2014-01-02
- Filing Date:
- 2014-01-02
- Accepted Time:
- 2014-01-02 17:31:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1522480 | F John Mauldin | C/O Galectin Therapeutics Inc. 4960 Peachtree Industrial Blvd, Ste 240 Norcross GA 30071 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-01-02 | 618 | $8.01 | 18,074 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,947 | Indirect | By Trust |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2013.